Savara Inc.
SVRANASDAQHealthcare● Active
$5.17
+$0.08(+1.47%)
Market Cap$1.1B
P/E Ratio—
52W High$7.005
52W Low$1.98
Savara Inc. (SVRA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SVRA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.15
Est. -$0.14 · -7.1%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS
SVRA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.14 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.14 | -$0.15 | -7.1% | — | $0.00B | — |
| ▼ Q1 FY2026 | Mar 13, 2026 | -$0.12 | -$0.13 | -8.3% | — | — | — |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.13 | -$0.14 | -7.7% | — | — | — |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.12 | -$0.14 | -16.7% | — | — | — |
| — Q2 FY2025 | May 13, 2025 | -$0.12 | -$0.12 | +0.0% | — | — | — |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$0.11 | -$0.13 | -18.2% | $0.00B | — | — |
| — Q4 FY2024 | Nov 12, 2024 | -$0.11 | -$0.11 | +0.0% | — | — | — |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.14
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$0.15
EPS Est.
-$0.14
EPS Surpr.
-7.1%
Revenue
—
Q1 FY2026
Mar 13, 2026Miss
EPS Actual
-$0.13
EPS Est.
-$0.12
EPS Surpr.
-8.3%
Revenue
—
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.14
EPS Est.
-$0.13
EPS Surpr.
-7.7%
Revenue
—
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.14
EPS Est.
-$0.12
EPS Surpr.
-16.7%
Revenue
—
Q2 FY2025
May 13, 2025
EPS Actual
-$0.12
EPS Est.
-$0.12
EPS Surpr.
+0.0%
Revenue
—
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$0.13
EPS Est.
-$0.11
EPS Surpr.
-18.2%
Revenue
$0.00B
Q4 FY2024
Nov 12, 2024
EPS Actual
-$0.11
EPS Est.
-$0.11
EPS Surpr.
+0.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.07 | $-0.07 | $-0.07 | 2 |
| Q3 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q2 FY2027 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Q1 FY2027 | $-0.11 | $-0.11 | $-0.11 | 2 |
| Q4 FY2026 | $-0.10 | $-0.10 | $-0.10 | 2 |
| Q3 FY2026 | $-0.16 | $-0.14 | $-0.13 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -7.1% | $5.12 | $5.08 | -0.78% |
| ▼ Q1 FY2026 | Mar 13, 2026 | -8.3% | $5.32 | $5.25 | -1.32% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -7.7% | $4.33 | $4.12 | -4.85% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -16.7% | $2.58 | $2.70 | +4.65% |
| ▲ Q2 FY2025 | May 13, 2025 | +0.0% | $3.02 | $2.97 | -1.66% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -18.2% | $2.70 | $2.78 | +2.96% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +0.0% | $4.07 | $3.83 | -5.90% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -9.1% | $3.98 | $4.10 | +3.02% |
Q2 FY2026-0.78%
Report Date
May 12, 2026
EPS Beat/Miss
-7.1%
Price Before
$5.12
Price After
$5.08
Q1 FY2026-1.32%
Report Date
Mar 13, 2026
EPS Beat/Miss
-8.3%
Price Before
$5.32
Price After
$5.25
Q4 FY2025-4.85%
Report Date
Nov 12, 2025
EPS Beat/Miss
-7.7%
Price Before
$4.33
Price After
$4.12
Q3 FY2025+4.65%
Report Date
Aug 13, 2025
EPS Beat/Miss
-16.7%
Price Before
$2.58
Price After
$2.70
Q2 FY2025-1.66%
Report Date
May 13, 2025
EPS Beat/Miss
+0.0%
Price Before
$3.02
Price After
$2.97
Q1 FY2025+2.96%
Report Date
Mar 27, 2025
EPS Beat/Miss
-18.2%
Price Before
$2.70
Price After
$2.78
Q4 FY2024-5.90%
Report Date
Nov 12, 2024
EPS Beat/Miss
+0.0%
Price Before
$4.07
Price After
$3.83
Q3 FY2024+3.02%
Report Date
Aug 12, 2024
EPS Beat/Miss
-9.1%
Price Before
$3.98
Price After
$4.10
Avg Beat Reaction-3.78%
Avg Miss Reaction+0.61%
Beat Rate2 / 8 quarters
Largest Move-5.90% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SVRA ends December
Savara Inc. (SVRA) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.15 — missing the analyst consensus of $-0.14 by -7.1%. The next SVRA earnings date is expected around September 1, 2026.
Each quarter, investors track SVRA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SVRA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SVRA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SVRA earnings · 5 questionsSavara Inc.'s next earnings report is expected around September 1, 2026. SVRA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SVRA historically reports after market close (AMC).
SVRA earnings datewhen is SVRA earningsSVRA next earnings datewhen does SVRA report earningsSVRA earnings calendar
▸ Source: FMP · Savara Inc. SEC filings · US GAAP · Savara Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026